Are GLP-1s Performance-Enhancing Drugs?
Serena Williams's return to tennis has raised questions about the use of GLP-1 weight-loss medications as potential performance-enhancing drugs. Williams, a paid spokesperson for a telehealth company that specializes in such medications, has credited the drug tirzepatide with helping her lose weight and improve her training. The World Anti-Doping Agency is monitoring the use of GLP-1s, but experts are divided on whether they have the potential to improve athleticism.
- ▪Serena Williams used a GLP-1 weight-loss medication to lose 34 pounds and improve her training.
- ▪The World Anti-Doping Agency is keeping a close eye on the use of GLP-1s in sports, but has not yet banned them.
- ▪Experts are divided on whether GLP-1s have the potential to improve athleticism, with some arguing that they could exacerbate eating disorders.
The Atlantic files mainly under culture. We currently carry 362 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Atlantic |
| Canonical URL | https://www.theatlantic.com/health/2026/06/glp1-weight-loss-doping-sports-serena-williams/687634/?utm_source=feed |
| Publication time | 2026-06-20T09:00:00-04:00 |
| Retrieval time | 2026-06-20T13:02:17.493Z |
| Last seen | 2026-06-20T13:02:17.493Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | q4THYlmE-z-A |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
HealthAre GLP-1s Performance-Enhancing Drugs?A weight-loss medication eased Serena Williams’s comeback. Experts can’t agree on whether that’s doping.By Nicholas FlorkoIllustration by Lucy Naland. Sources: Michael Siluk / UCG / Universal Images Group / Getty; Paul Harding / Getty.June 20, 2026, 9 AM ET ShareSave Before Serena Williams picked up her racket at London’s Andy Murray Arena last week, two questions hung over her return to tennis.First: How would she do? She answered that, in her first competition in nearly four years, by winning. The 44-year-old and her doubles partner, the 19-year-old Victoria Mboko, ended up besting the third seed in their opening match of the Queen’s Club tournament.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Atlantic.
Discussion
0 commentsMore from The Atlantic
